The Report: CRISPR Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 – 2021
Several attempts have been made in the past to alter gene functions. Coming of CRISPR to the limelight seems to have answered these attempts to some extent. CRISPR/CAS9 is being used aggressively these days as a targeted genome editing tool. The growing usage of CRISPR in genome editing indicates a solid growth in the global genome editing market in the coming days. There are number of factors driving the overall market but there is also another side of the coin which makes the situation little dicey for the entire market. Let us have a closer look at the overall scenario.
Technology is impacting every segment in a splendid way. This growing penetration of technology has brought a new era in the molecular biology. There has been a tremendous increase in the number of pharmaceutical and biotechnology industries over time and it shows no concrete signs of turning back sooner. Instead, it is expected to accelerate seeing a good growth in the genome editing market. It can be useful in agriculture also as there is growing demand for GMO or organic crops. CRISPR can fulfill the requirement of synthetic genes. The global rise in the production of genetically modified crops is also expected to drive this market ahead in future.
The global genome editing market is segmented into many segments. The experts believe that the cell line engineering will be the segment holding the largest share in the global genome market followed by animal genetic engineering segment. North America is still the most promising market for genome editing market with lot of growth opportunities. But the APAC region is set to show a double digit growth due to number expansion of leading pharmaceutical and biotechnology industries in these regions due to ample raw material, cohesive government policies and many more.
Moving on, there is a considerable increase in the healthcare spending in the recent times. The leading companies have increased their budget for R&D which is a good sign and will be a key growth driver for the global genome editing market.
Occams business Research & Consulting has published a report titled “CRISPR Market Report, Genome Editing Market Report” The aforementioned report also uncovers there would be a significant development of the global CRISPR market in regions such as North America, LAMEA, Asia Pacific and Europe.